TITLE:
An 8 Week Depression Study In Adults Diagnosed With Major Depressive Disorder

CONDITION:
Major Depressive Disorder (MDD)

INTERVENTION:
Radafaxine

SUMMARY:

      A Placebo Controlled Study Evaluating Efficacy, Safety and Tolerability of Radafaxine in
      Patients with Major Depressive Disorder (MDD)
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 64 Years
Criteria:

        Inclusion Criteria:

          -  Diagnosis of Major Depressive Disorder (MDD)

          -  Duration of current depressive episode 12 weeks - 24 months

          -  Patients can read and write at a level sufficient to provide a signed consent

          -  If female, patients must be practicing an acceptable method of birth control

        Exclusion Criteria:

          -  Patients have other psychiatric disorders that would affect patient's response to
             treatment

          -  Patients have not responded to two or more adequate courses of antidepressant therapy

          -  Patients cannot be currently abusing illicit drugs or alcohol

          -  Patients are not currently receiving psychotherapy

          -  Patients have received electroconvulsive therapy within 6 months prior to screening

          -  Patients are pregnant or lactating
      
